Latest news
Cantor Fitzgerald Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $22 - MoomooMoomoo · Fri, 07 Aug 2026 18:47:16 GMTKorro Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 14:47:31 GMTKorro Bio Reports $18.9 Million Q2 Net Loss - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:25:00 GMTKorro Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:19:50 GMTKorro Bio Swaps 1.0M Shares for Pre-Funded Warrants to Venrock at $0.001 Exercise Price - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTKorro Bio, Inc. Q2 2026: Revenue $0M, Net loss $(18.9)M, EPS $(1.07) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:11:00 GMTKorro Bio (KRRO) CEO sells 5,802 shares of stock to cover taxes - Stock TitanStock Titan · Wed, 05 Aug 2026 20:05:53 GMTKorro Bio, Inc. Revenue Breakdown – NASDAQ:KRRO - TradingViewTradingView · Mon, 27 Jul 2026 09:12:37 GMT